These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12921230)

  • 21. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.
    Yang W; Kahler KH; Fellers T; Orloff J; Chang J; Bensimon AG; Wu EQ; Fan CP; Yu AP
    J Med Econ; 2011; 14(3):267-78. PubMed ID: 21446895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating research into practice: are physicians following evidence-based guidelines in the treatment of hypertension?
    Holmes JS; Shevrin M; Goldman B; Share D
    Med Care Res Rev; 2004 Dec; 61(4):453-73. PubMed ID: 15536209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance with Joint National Committee 7 guidelines in hypertension management in a teaching institution.
    Jami P; Smith P; Moningi S; Moningi V; Martin SA; Rosencrance G; Reyes BJ
    Am J Med Qual; 2007; 22(4):251-8. PubMed ID: 17656729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial therapy for uncomplicated hypertension: insights from the alphabetic maze of recent studies.
    Stewart JR; Yeun JY
    Minerva Med; 2003 Aug; 94(4):215-27. PubMed ID: 14605587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of four angiotensin II receptor blockers in the treatment of hypertension.
    Miller LA; Wade R; Dai D; Cziraky MJ; Ramaswamy K; Panjabi S
    Curr Med Res Opin; 2010 Jun; 26(6):1307-20. PubMed ID: 20370377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension: interrupted time-series analysis.
    Fretheim A; Håvelsrud K; MacLennan G; Kristoffersen DT; Oxman AD
    PLoS Med; 2007 Jul; 4(7):e232. PubMed ID: 17622192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines.
    Clause SL; Hamilton RA
    Ann Pharmacother; 2002 Oct; 36(10):1505-11. PubMed ID: 12243597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis.
    Fretheim A; Aaserud M; Oxman AD
    BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
    Furtado C; Pinto M
    Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The costs of treating hypertension: what are the long-term realities of cost containment and pharmacoeconomics?
    Elliott WJ
    Postgrad Med; 1996 Apr; 99(4):241-8, 251-2. PubMed ID: 8604411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents.
    Small RE; Freeman-Arnold SB; Goode JV; Pyles MA
    Pharmacotherapy; 1997; 17(5):1011-6. PubMed ID: 9324190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
    Giverhaug T; Falck A; Eriksen BO
    J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extent of use of immediate-release formulations of calcium channel blockers as antihypertensive monotherapy by primary care physicians: multicentric study from Bahrain.
    Sequeira RP; Jassim Al Khaja KA; Mathur VS
    J Postgrad Med; 2002; 48(3):172-5. PubMed ID: 12432188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of Hypertensive Prescribing Practices (SHyPP): A National Survey of Primary Care Physicians.
    Schulman KA; Mehta SS; Gersh BJ; Schneider EC; Wilcox CS
    J Clin Hypertens (Greenwich); 1999 Oct; 1(2):106-114. PubMed ID: 11416601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.